Mulmit

Scilex Holding CoScilex Holding Co

SCLX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3130,253,000-346,007,000-374,053,000-36.48
2024-12-3156,590,000-83,396,000-72,807,000-8.05
2023-12-3146,743,000-105,431,000-114,331,000-1.28
2022-12-3138,034,000-50,634,000-23,364,000-0.17
2021-12-3131,317,000-35,838,000-88,424,000-0.67

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-20Scilex Holding Co50,000,000
2026-07-03SCLX Stock Acquisition JV LLC500,000
2026-04-17Ma Stephen HoiCFO, COO and Secretary650,000
2026-04-17Ji HenryExec Chair, CEO and President650,000
2026-04-16Ji HenryExec Chair, CEO and President3,250,000
2026-01-14Scilex Holding Co5,115,586
2026-01-13Scilex Holding Co175,139
2026-01-12Scilex Holding Co10,674,816
2026-01-08Scilex Holding Co3,824,201
2026-01-07Scilex Holding Co4,835,581
2026-01-06Scilex Holding Co6,053,708
2025-12-30Scilex Holding Co9,657,300

8-K events

FiledItems
2026-08-12Entry into a material agreement · Financial statements and exhibits
2026-07-22Entry into a material agreement · Completed acquisition or disposition of assets · Financial statements and exhibits
2026-07-06Entry into a material agreement · Unregistered sales of equity securities · Regulation FD disclosure · Financial statements and exhibits
2026-06-29Entry into a material agreement · Unregistered sales of equity securities
2026-06-24Submission of matters to a vote · Financial statements and exhibits
2026-05-11Other events · Financial statements and exhibits
2026-05-05Entry into a material agreement · Regulation FD disclosure · Financial statements and exhibits
2026-04-28Entry into a material agreement
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.